ATA159197A - Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren - Google Patents

Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren

Info

Publication number
ATA159197A
ATA159197A AT0159197A AT159197A ATA159197A AT A159197 A ATA159197 A AT A159197A AT 0159197 A AT0159197 A AT 0159197A AT 159197 A AT159197 A AT 159197A AT A159197 A ATA159197 A AT A159197A
Authority
AT
Austria
Prior art keywords
pharmaceutical preparation
preparation containing
containing vitamin
individual factors
dependent individual
Prior art date
Application number
AT0159197A
Other languages
English (en)
Other versions
AT409334B (de
Inventor
Yendra Dr Linnau
Peter Dr Turecek
Hans-Peter Schwarz
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AT0159197A priority Critical patent/AT409334B/de
Application filed by Immuno Ag filed Critical Immuno Ag
Priority to CA002304396A priority patent/CA2304396A1/en
Priority to HU0003681A priority patent/HUP0003681A1/hu
Priority to BR9812222-3A priority patent/BR9812222A/pt
Priority to JP2000512565A priority patent/JP2001517636A/ja
Priority to EP98944886A priority patent/EP1015020A1/de
Priority to PCT/AT1998/000224 priority patent/WO1999015196A1/de
Priority to SK402-2000A priority patent/SK4022000A3/sk
Priority to AU92449/98A priority patent/AU743102B2/en
Priority to NO20001415A priority patent/NO20001415L/no
Publication of ATA159197A publication Critical patent/ATA159197A/de
Application granted granted Critical
Publication of AT409334B publication Critical patent/AT409334B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
AT0159197A 1997-09-19 1997-09-19 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren AT409334B (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AT0159197A AT409334B (de) 1997-09-19 1997-09-19 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
HU0003681A HUP0003681A1 (hu) 1997-09-19 1998-09-17 K-vitamin-függő egyedi faktorokat tartalmazó gyógyszerkészítmény
BR9812222-3A BR9812222A (pt) 1997-09-19 1998-09-17 Preparação farmacêutica separada de complexo de protrombina, preparação diagnóstica, e, utilização de uma preparação
JP2000512565A JP2001517636A (ja) 1997-09-19 1998-09-17 ビタミンｋ依存性単一因子を含む医薬調製物
CA002304396A CA2304396A1 (en) 1997-09-19 1998-09-17 A pharmaceutical preparation comprising vitamin k-dependent single factors
EP98944886A EP1015020A1 (de) 1997-09-19 1998-09-17 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
PCT/AT1998/000224 WO1999015196A1 (de) 1997-09-19 1998-09-17 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
SK402-2000A SK4022000A3 (en) 1997-09-19 1998-09-17 PHARMACEUTICAL SUBSTANCE CONTAINING VARIOUS VITAMIN K-DEPENDENTì (54) FACTORS
AU92449/98A AU743102B2 (en) 1997-09-19 1998-09-17 Pharmaceutical substance containing various vitamin K-dependent factors
NO20001415A NO20001415L (no) 1997-09-19 2000-03-17 Farmasøytikum inneholdende vitamin-K-avhengige faktorer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0159197A AT409334B (de) 1997-09-19 1997-09-19 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren

Publications (2)

Publication Number Publication Date
ATA159197A true ATA159197A (de) 2001-12-15
AT409334B AT409334B (de) 2002-07-25

Family

ID=3516739

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0159197A AT409334B (de) 1997-09-19 1997-09-19 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren

Country Status (10)

Country Link
EP (1) EP1015020A1 (de)
JP (1) JP2001517636A (de)
AT (1) AT409334B (de)
AU (1) AU743102B2 (de)
BR (1) BR9812222A (de)
CA (1) CA2304396A1 (de)
HU (1) HUP0003681A1 (de)
NO (1) NO20001415L (de)
SK (1) SK4022000A3 (de)
WO (1) WO1999015196A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2357751C2 (ru) 2001-12-21 2009-06-10 Ново Нордиск Хелт Кэр Аг Жидкая композиция полипептидов фактора vii
AU2003213146A1 (en) * 2002-03-08 2003-09-22 Eli Lilly And Company Activated protein c formulations
EP2283856B1 (de) 2002-06-21 2017-09-20 Novo Nordisk Health Care AG Stabiliserte feste Zusammensetzungen von Faktor VIIa Polypeptiden
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
DE602004025100D1 (de) 2003-05-23 2010-03-04 Novo Nordisk Healthcare Ag Stabilisierung von proteinen in lösung
ES2382157T3 (es) 2003-06-25 2012-06-05 Novo Nordisk Health Care Ag Composición líquida de polipépttidos del factor VII
ES2574581T3 (es) 2003-08-14 2016-06-20 Novo Nordisk Health Care Ag Composición farmacéutica líquida acuosa de polipéptidos de tipo Factor VII
AU2004298789A1 (en) 2003-12-19 2005-06-30 Novo Nordisk Health Care Ag Stabilised compositions of factor VII polypeptides
JP2008530208A (ja) * 2005-02-16 2008-08-07 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 万能前凝固薬
JP2008531692A (ja) 2005-03-04 2008-08-14 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 凝固及び線維素溶解カスケードのモジュレーター
WO2009046194A2 (en) 2007-10-05 2009-04-09 The Board Of Trustees Of The University Of Illinois Fibrin sealant
US20100297257A1 (en) 2007-11-09 2010-11-25 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs) Anticoagulant antagonist and hemophillia procoagulant
KR20130136988A (ko) * 2010-10-06 2013-12-13 메디뮨 리미티드 지혈 장애를 치료하기 위한 인자 ii 및 피브리노겐
EP3579857B1 (de) * 2017-02-09 2022-04-06 CSL Behring GmbH Blutgerinnungsfaktorersatzprodukt zur verwendung bei der behandlung oder prophylaxe von blutungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729822D0 (en) * 1987-12-22 1988-02-03 Central Blood Lab Authority Chemical process
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
DE4430205A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung
ATE296109T1 (de) * 1996-03-20 2005-06-15 Baxter Ag Pharmazeutisches präparat zur behandlung von blutgerinnungsstörungen

Also Published As

Publication number Publication date
HUP0003681A1 (hu) 2001-02-28
SK4022000A3 (en) 2000-09-12
EP1015020A1 (de) 2000-07-05
AU9244998A (en) 1999-04-12
CA2304396A1 (en) 1999-04-01
NO20001415D0 (no) 2000-03-17
AT409334B (de) 2002-07-25
AU743102B2 (en) 2002-01-17
JP2001517636A (ja) 2001-10-09
WO1999015196A1 (de) 1999-04-01
NO20001415L (no) 2000-05-19
BR9812222A (pt) 2000-07-18

Similar Documents

Publication Publication Date Title
DE69831620D1 (de) Arzneizubereitungen enthaltend Kannabinoide
NO20002025D0 (no) Modifiserte vitamin K -avhengige polypeptider
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
NO20001776D0 (no) Medikamenter
PT1124779E (pt) Analogos da vitamina d
ID24654A (id) Formulasi farmasi omeprazola
DE69833739D1 (de) Kosmetisches Präparat
ID23299A (id) Formulasi-formulasi farmasi
DK1466615T3 (da) Farmaceutisk præparat
PT1235777E (pt) Analogos da vitamina d
IS5536A (is) Efnablanda fyrir snyrtivörur
ATA159197A (de) Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
IS4774A (is) Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum
IS5331A (is) Ný lyfjablanda
ZA982073B (en) Pharmaceutical preparation
ATE298576T1 (de) Arzneizubereitungen
ATA6897A (de) Präparation umfassend thiolgruppen-hältige proteine
EE03511B1 (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
ATE237309T1 (de) Arzneizubereitungen
DE59807819D1 (de) Duftstoff-enthaltende Zubereitung
DE69809375T2 (de) Antikrebs-Zubereitung
DE29811862U1 (de) Vitamin-Tablettenspender
ID23663A (id) Persiapan kaprolaktam
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste
DE29719198U1 (de) Flavono/Flavonoid-Zubereitung

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee